The Only Complete Online Marketing Firm
Sunday, April 19, 2015
Immune Checkpoint Drug Active in NSCLC
(MedPage Today) -- Tumors with at least 50% PD-L1 expression associated with unexpected improvement.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment